Thread Research lands $50m infusion for decentralized trial tech
The clinical research tech provider has received a capital commitment from healthcare industry investors to advance its decentralized trial solutions.
The clinical research tech provider has received a capital commitment from healthcare industry investors to advance its decentralized trial solutions.
The company is joining with Zosano Pharma to aid the commercialization and distribution of Qtrypta, a transdermal migraine treatment candidate.
The company has released a report revealing how clinical trial professionals are handling start-up, before and after COVID-19 first impacted the industry.